Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: Facile approach for surfactant-free synthesis of Au@ginsenoside Rh2 nanoparticles and researches on anticancer activity

Fig. 2

A Cell viability of different cancer cell lines A375, A549, U251, HepG-2 and normal cells 293T and HUVEC treated with Au@ginsenoside Rh2. B The LDH release of normal cells and cancer cells induced by different concentration of Au@ginsenoside Rh2 NPs. The values represent mean ± SD (n = 3, *p < 0.05, vs control). The results of LDH release are also shown as a relative O.D. value to control group (0 μg/mL)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us